Transdermal Lovastatin Enhances Fracture Repair in Rats

被引:39
作者
Gutierrez, Gloria E. [1 ,2 ,3 ]
Edwards, James R. [1 ,2 ]
Jarrett, Ian R. [3 ]
Nyman, Jeffry S. [4 ]
Mccluskey, Brandon [3 ]
Rossini, Gianni [3 ]
Flores, Alda [3 ]
Neidre, Daria B. [5 ]
Mundy, Gregory R. [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA
[3] OsteoScreen, San Antonio, TX USA
[4] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX USA
[5] Univ Texas Austin, Austin, TX 78712 USA
关键词
fracture; statins; transdermal; osteoporosis; orthopedics; fracture repair; HMG-CoA reductase inhibitors;
D O I
10.1359/JBMR.080603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Statins have been shown to stimulate BMP2 transcription and bone formation. This raises the possibility that they could be useful for enhancing rates of fracture repair. Observational Studies in patients treated with oral statins for lipid-lowering have been controversial. The likely reason for their inconsistent effects is that the statin concentration reaching, the periphery Was too low after oral administration to produce a reproducible biologic effect. Thus, We examined the effects of lovastatin (LV) given transdermally in a well-described preclinical model of fracture repair. Effects oil the healing fracture callus were assessed by biomechanical strength, radiographs, and quantitative morphology. LV was administered transdermally (TD) for 5 days after fracture in several doses (0.1-5 mg/kg/d) and compared with vehicle-treated control rats and rats treated with LV by oral gavage (PO) at 5-25 mg/kg/d for 5 days from the day of fracture. Radiological evaluation of bones treated with TD LV showed enhanced fracture repair at 2 and 6 wk. BMD in the callus area at 6 wk was also increased in the TD group compared with vehicle-treated controls (p < 0.05). The force required to break TD-treated bones (0.1 mg/kg/d for 5 days) was 42% greater than vehicle-treated controls (p < 0.02), and there was a 90% increase in stiffness (p < 0.01). PO LV at much higher doses (10 and 25 mg/kg/d) showed increased stiffness but no change ill other biomechanical properties. By histological examination, a significant increase was also observed in the size of the callus, surrounding proliferating cell nuclear antigen-positive cells, and osteoblast and osteoclast number ill TD-treated rats compared with Controls at clay 8 after fracture (n = 6). In summary, we found that TD LV in low doses accelerates fracture healing, Whereas, 10-fold the lipid-lowering close was required to produce any effect when it was administered orally. These studies provide valuable information oil the potential of statins and TD delivery Lis a new and effective therapeutic modality in fracture repair.
引用
收藏
页码:1722 / 1730
页数:9
相关论文
共 42 条
  • [1] Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity
    Aguirre, J
    Buttery, L
    O'Shaughnessy, M
    Afzal, F
    de Marticorena, IF
    Hukkanen, M
    Huang, P
    MacIntyre, I
    Polak, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) : 247 - 257
  • [2] Use of statins and fracture - Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials
    Bauer, DC
    Mundy, GR
    Jamal, SA
    Black, DM
    Cauley, JA
    Ensrud, KE
    van der Klift, M
    Pols, HAP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) : 146 - 152
  • [3] Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia
    Bax, BE
    Wozney, JM
    Ashhurst, DE
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1999, 65 (01) : 83 - 89
  • [4] BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115
  • [5] Expression of bone morphogenetic proteins in fracture healing
    Bostrom, MPG
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1998, (355) : S116 - S123
  • [6] Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
    Chan, KA
    Andrade, SE
    Boles, M
    Buist, DSM
    Chase, GA
    Donahue, JG
    Goodman, MJ
    Gurwitz, JH
    LaCroix, AZ
    Platt, R
    [J]. LANCET, 2000, 355 (9222) : 2185 - 2188
  • [7] Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing
    Cho, TJ
    Gerstenfeld, LC
    Einhorn, TA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (03) : 513 - 520
  • [8] Rhabdomyolysis after taking atorvastatin with gemfibrozil
    Duell, PB
    Connor, WE
    Illingworth, DR
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (03) : 368 - 369
  • [9] Recombinant human bone morphogenetic protein 2 enhances bone heating in an experimental model of fractures at risk of non-union
    Eckardt, H
    Christensen, KS
    Lind, M
    Hansen, ES
    Hall, DWR
    Hvid, I
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2005, 36 (04): : 489 - 494
  • [10] Oral statins and increased bone-mineral density in postmenopausal women
    Edwards, CJ
    Hart, DJ
    Spector, TD
    [J]. LANCET, 2000, 355 (9222) : 2218 - 2219